Make your money go further for just 25p per day

Abcam plc (AIM: ABC) - usual excellence from another of AIM’s blue chips and one of our favourites

09/03/2015 · Abcam (ABC) 

The global leader in the supply of life science research tools, and one one of AIM’s huge success stories announced positive interim results for the six months ended 31 December 2014 demonstrating that the growth engine is still firing.

With its headquarters in Cambridge, Abcam was admitted to AIM in 2005 and has delivered handsomely for shareholders. The Group is a true global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

In the 6 months to 31st December product revenue increased to £62.7m (H1 2014: £56.8m), representing growth of 16.7% on a constant currency basis and 10.4% on a reported basis.

Total revenue increased to £66.7m (H1 2014: £61.9m), representing growth of 13.8% on a constant currency basis and 7.7% on a reported basis

Gross margins fell marginally to 70.4% (H1 2014: 70.9%), reflecting some currency headwinds in the period but the adjusted operating margin was still a whopping 35.4% (H1 2014: 36.8%), with reported operating margin 32.8% (H1 2014: 34.1%). EBITDA was £25.8m, representing growth of 5.8% over H1…

Sign up and read the full article

Register to continue reading this article.

Get FREE access now

Already a member? Login

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world


Become a Champion Investor for as little as £3.20 per report or get a year's worth of money-making analysis for just £90.


More on Abcam

Follow the directors: who’s buying?

12/12/2018 · News & Insights
The last few weeks have seen plenty of director buying from small caps but blue-chip managers…

It’s reporting season….and the accounting shenanigans are coming thick and fast!

14/09/2018 · News & Insights
With the summer lull behind us, many public companies, large and small, have been issuing results…

Why would the Chancellor attack AIM tax reliefs?

13/10/2017 · News & Insights
Investor’s Champion has researched AIM companies for over 12 years and has always highlighted the Inheritance…

Stunning results from this high growth AIM company are the highlight of the week?

13/11/2015 · News & Insights
​The week saw a small specialist engineering company deliver some absolutely stunning results. With seemingly plenty…

Abcam (AIM:ABC) the AIM star deploys its cash pile

11/11/2015 · News & Insights
The global leader in the supply of life science research tools and one of AIM’s true…

More from the News & Insights

AIM heroes, villains and an exciting IPO, at last

M&S and Royal Mail: Is it too late to turn things around?

22/05/2019 · Marks & Spencer · Ocado · Royal Mail

Scapa Group - Bonkers valuation of the week

21/05/2019 · Scapa Group